Home » Newsletters » BioWorld

BioWorld

Sep. 2, 1993

View Archived Issues

PERSEPTIVE TO ACQUIRE MASS SPECTROMETRY COMPANY

CLOT-BUSTER STUDY RESULTS PUBLISHED

IMMUNOGEN TESTS ONCOLYSIN S

IVAX COMPLETES JOHNSON PRODUCTS MERGER

STOCK PURCHASE BRINGS VIRATEK $14M

VESTAR ENTERS TAXOL MARKET

FDA POSTPONES REVIEW OF RESPIVIR

FDA APPROVES HYGEIA PHARMACEUTICALS TRIALS

CYANOTECH GETS FUNDING FOR PRODUCTION FACILITY

SOUTH KOREA OKS BTG'S BIOLON By Brenda Sandburg

APS COMPLETES PHASE III TRIALS